Helen T Chifotides

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

American journal of hematology

Cancers

Leukemia

Journal of hematology & oncology

The University of Texas MD Anderson Cancer Center

National and Kapodistrian University of Athens (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Texas MD Anderson Cancer Center

United States

Senior Research Scientist

Houston Methodist Research Institute

United States

Scientific Writer

Texas A&M University

United States

Research Scientist and Scientific Writer :: Chemistry

Texas A&M University

United States

Senior Research Associate and Scientific Writer :: Chemistry

General Hospital of Chest Diseases

Greece

Senior Biochemist

Education History

National and Kapodistrian University of Athens

Greece

PHD :: Chemistry, Bioinorganic

National and Kapodistrian University of Athens

Greece

BSC :: Chemistry

Publications

Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Andrea Duminuco, Helen T Chifotides, Sebastiano Giallongo, Cesarina Giallongo, Daniele Tibullo, Giuseppe Alberto Maria Palumbo
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis. Cancers 16 (1) (2023)
Andrea Duminuco, Helen T Chifotides, Sebastiano Giallongo, Cesarina Giallongo, Daniele Tibullo, Giuseppe Alberto Maria Palumbo
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis. Cancers 16 (1) (2023)
Helen T Chifotides, Srdan Verstovsek, Prithviraj Bose
Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments. Cancers 15 (13) (2023)
Andrea Duminuco, Helen T Chifotides, Sebastiano Giallongo, Cesarina Giallongo, Daniele Tibullo, Giuseppe Alberto Maria Palumbo
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis. Cancers 16 (1) (2023)
Helen T Chifotides, Prithviraj Bose, Srdan Verstovsek
Momelotinib: an emerging treatment for myelofibrosis patients with anemia. Journal of hematology & oncology 15 (1) (2022)
Siba El Hussein, Helen T Chifotides, Joseph D Khoury, Srdan Verstovsek, Beenu Thakral
Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update. Cancers 14 (14) (2022)
John O Mascarenhas, Hélène F E Gleitz, Helen T Chifotides, Claire N Harrison, Srdan Verstovsek, Alessandro Maria Vannucchi, Raajit K Rampal, Jean-Jacques Kiladjian, William Vainchenker, Ronald Hoffman, Rebekka K Schneider, Alan F List
Biological drivers of clinical phenotype in myelofibrosis. Leukemia (2022)
Helen T Chifotides, Prithviraj Bose, Srdan Verstovsek
Givinostat: an emerging treatment for polycythemia vera. Expert opinion on investigational drugs 29 (6) (2020)

Helen T Chifotides.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Helen T Chifotides